AXL-1717

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 0F35AOI227

Structure
InChI Key YJGVMLPVUAXIQN-HAEOHBJNSA-N
Smile COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
InChI
InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H22O8
Molecular Weight 414.41
AlogP 2.41
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 92.68
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 30.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Insulin-like growth factor I receptor inhibitor PubMed PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - - 27

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Adenocarcinoma of Lung 2 D000077192 ClinicalTrials
Hematologic Neoplasms 1 D019337 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Oligodendroglioma 1 D009837 ClinicalTrials
Gliosarcoma 1 D018316 ClinicalTrials
Astrocytoma 1 D001254 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 75251
ChEMBL CHEMBL283120
DrugBank DB12802
EPA CompTox DTXSID80197245
FDA SRS 0F35AOI227
Guide to Pharmacology 7873
SureChEMBL SCHEMBL159598
ZINC ZINC000004098919
CONTENTS